Sign In
6 Sep 2013 13:58
ο»Ώ
6 September 2013
PuriCore plc
("PuriCore" or the "Company")
Β
Director Dealing
Β
Β
PuriCoreΒ (LSE: PURI), a global company focused on safely and effectively protecting people from the spread of infectious pathogens, todayΒ announces a director dealing, in accordance with the Disclosure and Transparency Rules. The Company announces that on the 5th and 6th September 2013, the following Director purchased shares in the Company, as set out below.
Β
Name | Date purchased | Number of shares purchased | Purchase price of shares | Shareholding following the acquisition | % of issued share capital |
Daniel Hegglin Non-Executive Director | 5 Sept 2013 6 Sept 2013 | 50,000 550,000 | 40p 43p | Β Β | Β Β |
Total Dealing | 600,000 Β | 3,909,091 Β | 7.80% Β |
Β
Enquiries:
UK | US |
FTI Consulting | Sage Strategic Marketing |
Susan Stuart | Jennifer Guinan |
Victoria Foster Mitchell | +1 610.410.8111 |
+44 (0) 20 7831 3113 | jennifer@sagestrat.com |
Β
About PuriCore
PuriCore plc (LSE: PURI) is a global company focused on safely and effectively protecting people from the spread of infectious pathogens without causing harm to human health or the environment. PuriCore's antimicrobial technology and complementary products are used principally in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. PuriCore's breakthrough wound therapy solution is used to treat chronic and acute wounds including diabetic ulcers and burns as well as atopic dermatitis as dermatologic treatment products. In the Food & Agriculture market, PuriCore's portfolio provide savings to supermarket retailers in labour costs and improvements in inventory loss as well as address the issue of cross contamination of fresh produce and floral products. In addition, the Company is progressing in its research and development programmes in the UK on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.
Β
Β
Β
Β
Β
Β
Β
Follow the stocks
